Facet browsing currently unavailable
Page 1 of 5893 results
Sort by: relevance publication year
Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines JOURNAL ARTICLE published 3 June 2017 in Human Vaccines & Immunotherapeutics |
Letter from the Editor JOURNAL ARTICLE published 2 April 2020 in Human Vaccines & Immunotherapeutics |
Adding fuel to the fire: Immunogenic intensification JOURNAL ARTICLE published 2 November 2014 in Human Vaccines & Immunotherapeutics |
The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice JOURNAL ARTICLE published 3 July 2018 in Human Vaccines & Immunotherapeutics |
NIC23 JOURNAL ARTICLE published 12 June 2013 in Human Vaccines & Immunotherapeutics |
24 year outcomes of hepatitis B vaccination in Hangzhou, China JOURNAL ARTICLE published 3 August 2015 in Human Vaccines & Immunotherapeutics |
Profile JOURNAL ARTICLE published November 2013 in Human Vaccines & Immunotherapeutics |
Pentavalent vaccine JOURNAL ARTICLE published 16 September 2012 in Human Vaccines & Immunotherapeutics |
Mucosal and systemic antibody responses to potentialPseudomonas aeruginosavaccine protein antigens in young children with cystic fibrosis following colonization and infection JOURNAL ARTICLE published 18 March 2013 in Human Vaccines & Immunotherapeutics |
Letter on “Analysis on the risks of severe adverse events in rabies post-exposure prophylaxis and appropriate decision-making procedure” JOURNAL ARTICLE published 2 September 2019 in Human Vaccines & Immunotherapeutics |
Letter from the Editor JOURNAL ARTICLE published 2 December 2014 in Human Vaccines & Immunotherapeutics |
ASVAC2017: 6th Asian Vaccine Conference JOURNAL ARTICLE published 3 October 2017 in Human Vaccines & Immunotherapeutics |
Letter from the Editor JOURNAL ARTICLE published 3 June 2017 in Human Vaccines & Immunotherapeutics |
Potential impact of B lineage mismatch on trivalent influenza vaccine effectiveness during the 2015–2016 influenza season among nursery school children in Suzhou, China JOURNAL ARTICLE published 4 March 2018 in Human Vaccines & Immunotherapeutics |
Dengue vaccines: the road to failure or to success? JOURNAL ARTICLE published November 2020 in Human Vaccines & Immunotherapeutics |
Letter from the editor JOURNAL ARTICLE published November 2020 in Human Vaccines & Immunotherapeutics |
Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus JOURNAL ARTICLE published November 2020 in Human Vaccines & Immunotherapeutics |
A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II) JOURNAL ARTICLE published November 2020 in Human Vaccines & Immunotherapeutics Research funded by Merck (N/A) |
Mucosal immune responses to Vibrio cholerae O-specific polysaccharide in adults following oral vaccination not optimally assessed JOURNAL ARTICLE published 2 October 2020 in Human Vaccines & Immunotherapeutics |
A Syrian refugee with meningococcal empyema JOURNAL ARTICLE published 2 August 2020 in Human Vaccines & Immunotherapeutics |